Difficulty: Medium
Average Score: 94%
Practice
Which of the following statements refers to etidronate:
Correct answer
A
Rationale
The correct answer is A) Reduces osteoclast activity without significantly affecting osteoblasts; useful in treatment of Paget's disease.
This statement accurately describes etidronate, a bisphosphonate medication used in the treatment of Paget's disease. Bisphosphonates work by inhibiting osteoclast activity, leading to decreased bone resorption. This particular drug does not significantly affect osteoblasts, which are responsible for bone formation, making it useful in conditions where excessive bone breakdown is a concern, such as Paget's disease.
Option B is incorrect because monitoring serum phosphorus concentrations daily is not a specific requirement for oral etidronate administration. Option C is incorrect because etidronate is a first-generation bisphosphonate, not a second-generation one. Option D is incorrect as the bioavailability of etidronate does not necessarily increase with the administered dose.
In an educational context, understanding the mechanism of action and specific indications for bisphosphonates like etidronate is crucial for healthcare professionals involved in the management of bone disorders. This knowledge ensures safe and effective medication use, leading to improved patient outcomes.
This statement accurately describes etidronate, a bisphosphonate medication used in the treatment of Paget's disease. Bisphosphonates work by inhibiting osteoclast activity, leading to decreased bone resorption. This particular drug does not significantly affect osteoblasts, which are responsible for bone formation, making it useful in conditions where excessive bone breakdown is a concern, such as Paget's disease.
Option B is incorrect because monitoring serum phosphorus concentrations daily is not a specific requirement for oral etidronate administration. Option C is incorrect because etidronate is a first-generation bisphosphonate, not a second-generation one. Option D is incorrect as the bioavailability of etidronate does not necessarily increase with the administered dose.
In an educational context, understanding the mechanism of action and specific indications for bisphosphonates like etidronate is crucial for healthcare professionals involved in the management of bone disorders. This knowledge ensures safe and effective medication use, leading to improved patient outcomes.